Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite

Arthritis and Rheumatism

Volumn 52, Issue 1, 2005, Pages 80-83

  Grinnell, Susan ^a   Yoshida, Koji ^a   Jasin, Hugo E ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Division of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2; OXYGEN RADICAL; PEROXYNITRITE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MUMPS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, VIRAL; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-2; LYMPHOCYTES; MUMPS VIRUS; OXIDANTS; PEROXYNITROUS ACID; PHYTOHEMAGGLUTININS; REACTIVE OXYGEN SPECIES;

EID: 12344279824     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20760     Document Type: Article

References (15)

1. Jasin HE. Generation of IgG aggregates by the myeloperoxidase-hydrogen peroxide system. J Immunol 1983;130:1918-23.
2. Jasin HE. Oxidative cross-linking of immune complexes by human polymorphonuclear leukocytes. J Clin Invest 1988;81:6-15.
3. Uesugi M, Hayashi T, Jasin HE. Covalent cross-linking of immune complexes by oxygen radicals and nitrite. J Immunol 1998;161:1422-7.
4. Jasin HE. Cross-linking of immune complexes by human mononuclear phagocytes. Inflammation 1987;11:117-29.
5. Uesugi M, Yoshida K, Jasin HE. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 2000;165:6532-7.
6. Jasin HE. Mechanisms of tissue damage in rheumatoid arthritis. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 1128-52.
7. Fox DA. Etiology and pathogenesis of rheumatoid arthritis. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 1086-102.
8. Birnboim HC, Lemay AM, Lam DK, Goldstein R, Webb JR. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J Immunol 2003;171:528-32.
9. Jasin HE. Oxidative modification of inflammatory synovial fluid immunoglobulin G. Inflammation 1993;17:167-81.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Sager DS, Jasin HE. Bacterial lipopolysaccharide-induced immunoglobulin synthesis in blood mononuclear cells partially depleted of monocytes. Clin Exp Immunol 1982;47:645-52.
12. Silverman HA, Johnson JS, Vaughan JH, McGlamory JC. Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis Rheum 1976;19:509-15.
13. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
14. Blass S, Haferkamp C, Specker C, Schwochau M, Schneider M, Schneider EM. Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen. Ann Rheum Dis 1997;56:317-22.
15. Kaur H, Halliwell B. Evidence for nitric oxide-mediated damage in chronic inflammation: nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9.